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Abstract
Objective—To perform a systematic review and meta-analysis that quantitatively tests and 
summarizes the hypothesis that depression results in elevated oxidative stress and lower 
antioxidant levels.
Methods—We performed a meta-analysis of studies that reported an association between 
depression and oxidative stress and/or antioxidant status markers. PubMed and EMBASE 
databases were searched for articles published from January 1980 through December 2012. A 
random-effects model, weighted by inverse variance, was performed to pool standard deviation 
(Cohen’s d) effect size estimates across studies for oxidative stress and antioxidant status 
measures, separately.
Results—Twenty-three studies with 4980 participants were included in the meta-analysis. 
Depression was most commonly measured using the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition criteria. A Cohen’s d effect size of 0.55 (95% confidence interval = 
0.47–0.63) was found for the association between depression and oxidative stress, indicating a 
roughly 0.55 of 1-standard-deviation increase in oxidative stress among individuals with 
depression compared with those without depression. The results of the studies displayed 
significant heterogeneity (I2 = 80.0%, p < .001). A statistically significant effect was also observed 
for the association between depression and antioxidant status markers (Cohen’s d = −0.24, 95% 
confidence interval = −0.33 to −0.15).
Conclusions—This meta-analysis observed an association between depression and oxidative 
stress and antioxidant status across many different studies. Differences in measures of depression 
and markers of oxidative stress and antioxidant status markers could account for the observed 
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heterogeneity. These findings suggest that well-established associations between depression and 
poor heath outcomes may be mediated by high oxidative stress.
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INTRODUCTION
Individuals who experience more depression exhibit greater functional limitations, 
morbidity, and premature mortality than do individuals without depression. Research in the 
last 20 years has shown that the relationship between depression and its central nervous 
system influences the body’s physiological processes (1). Most of this research has been on 
the cardiovascular and endocrine systems. An increase in cortisol levels, activated by the 
hypothalamic-pituitary-adrenal axis, is one well-accepted explanation for the relationship 
between psychological distress, such as depression, and physical disease (1), including 
cardiovascular diseases and diabetes (2).
Oxidative stress is the imbalance between oxidative stress and antioxidant defenses, which 
leads to oxidized proteins, lipids, and nucleic acids. Higher oxidative stress is indicative of 
greater reactive oxygen species circulating the body. Antioxidants counteract the damaging 
effects of oxidative stress. Lower antioxidant status indicates fewer circulating antioxidant 
molecules to offset the oxidation of molecules. High oxidative stress or low antioxidant 
status are increasingly established in the biology of poor health outcomes and progression of 
a wide range of diseases. Previous research has shown that high oxidative stress is 
associated with the onset and progression of diabetes (3), atherosclerosis (4), and mortality 
(5). Oxidative stress is a candidate pathway that may link depression to physiological 
changes.
An association between depression and oxidative stress has been reported, although findings 
are inconsistent due to heterogeneous clinical populations, small sample sizes, and the use of 
varying measures of oxidative stress or antioxidant status (6). Published reviews in this 
subject area have systematically reviewed the literature and provide explanations for 
possible biological mechanisms (7–9), but have not quantitatively assessed the literature by 
performing a meta-analysis. Our goals in this article are to summarize this growing body of 
literature and evaluate the current state of evidence both qualitatively and quantitatively 
through the use of a meta-analysis.
METHODS
Search Strategy
A literature search of observational studies examining the association between depression 
and oxidative stress was performed. The search was conducted for articles published from 
January 1980 through December 2012 using PubMed and EMBASE electronic databases. 
These databases were searched without language or subject restrictions. Controlled 
vocabulary (MeSH and emtree) and keywords were used in the search strategy. Searches 
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involved several combinations of terms, including “depression” OR “depressive symptoms” 
OR “emotional depression” AND “protein carbonyls” OR “MDA” OR “glutathione” OR 
antioxidant markers, for example, “carotenoids” OR “SOD.” A complete list of the search 
terms used for each database is provided in Appendix A, Supplemental Digital Content 1, 
http://links.lww.com/PSYMED/A94. A bibliography search of included studies was done to 
identify additional studies.
Study Selection
Only observational human studies that examined the association between depression and 
oxidative stress and antioxidant status markers were included. Studies were excluded if they 
did not have a valid depression or oxidative stress (or antioxidant status) measure. All 
articles retrieved by our search strategy were imported and merged into RefWorks. Two 
coauthors (P.P. and S.L.S.) independently reviewed 2032 titles and abstracts for inclusion 
and classified the abstracts as “include” or “exclude.” Any disagreements in the abstracts 
review were adjudicated by consensus. Titles and abstracts categorized as exclude by both 
of the reviewers were excluded, and the reason for exclusion was documented. Agreement 
between the reviewers’ decisions on inclusion/exclusion of articles was assessed using 
Cohen’s k statistic. The k statistic for title and abstract inclusion/exclusion was 0.56, 
indicating moderate interrater agreement. Studies that were included based on title and 
abstract review underwent full-text review (n = 70). Forty-seven studies were excluded after 
full-text review for the following reasons: no measure of oxidative stress (n = 11), no 
measure of depression (n = 4), no comparison group (n = 4), insufficient data (n = 15), 
nonhuman study (n = 2), review article (n = 8), and studies reporting on the same study 
population (n = 3). The study selection process resulted in 23 articles that met study 
inclusion criteria (Fig. 1).
Data Extraction
Two coauthors (P.P. and L.J.S.) independently abstracted all included articles into a 
standardized excel spreadsheet. Disagreements or uncertainties were adjudicated by 
consensus. From each article, we abstracted a) characteristics of the study population, 
including sample size and age; b) measures of oxidative stress or antioxidant status, 
including how it was measured and in what fluid it was measured; and c) measures of 
depression. A complete list of the data abstraction fields is included in Appendix B, 
Supplemental Digital Content 2, http://links.lww.com/PSYMED/A95.
Statistical Analysis
Measures of depression and oxidative stress varied across studies. Comparable with other 
meta-analyses (10), a Cohen’s d effect size was calculated for each study to allow for 
comparability across studies because of varied outcome measures. In all included studies, 
depression had already been dichotomized as either nondepressed or depressed based on 
either clinical criteria from the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) (11–26) or other epidemiologic measures with specified cutoffs 
(27–33).
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For studies with multiple oxidative stress and antioxidant status measures, an effect size 
estimate was first computed for each individual oxidative stress and antioxidant status 
measure. This was calculated by taking the difference in the mean change in oxidative stress 
or antioxidant status measure between the nondepressed and depressed groups and dividing 
by the pooled standard deviation. These individual effect size estimates were then pooled to 
obtain a Cohen’s d effect size estimate within each study for oxidative stress and anti-
oxidant status, separately. A positive effect size estimate indicates either high oxidative 
stress or high antioxidant status. A negative effect size estimate indicates either low 
oxidative stress or low antioxidant status. A random-effects meta-analysis, weighted by 
inverse variance, was performed to pool the standard deviation (Cohen’s d) effect size 
estimates across studies for oxidative stress and antioxidant status measures, separately. A 
test for heterogeneity was performed to determine the presence of statistical heterogeneity or 
variation between the estimates of association for included studies. The presence of 
statistical heterogeneity provided justification for a random effects approach to the meta-
analysis. All analyses were conducted using STATA 11.0 (STATA Corp, College Station, 
TX).
Quality Assessment of Reported Studies
Following guidelines from the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) statement, we used the following items to assess study quality 
(34): clear description of participant eligibility and, for case-control studies, case 
ascertainment based on psychometric methods and comparable control selection; 
measurement of depression using reliable instruments; clear description of oxidative stress 
measurement; clear description of how depression and oxidative stress variables were 
handled in analyses; and control for potential confounders, such as excessive adiposity, 
recent infections or medication use, and presence of chronic disease or neurologic disorder, 
either by exclusion criteria or statistical adjustment.
RESULTS
Characteristics and Quality of Studies on Depression and Oxidative Stress
Sample Characteristics—Twenty-three published studies were included in this meta-
analysis (Table 1). A total of 4980 participants were recruited from community and clinical 
populations (Table 1). Studies were conducted in 10 countries: Turkey (11,12,16,19,21–
24,27), India (15,18,25), Japan (17,31), United States (26,29), China (32,33), Canada (13), 
Netherlands (30), Poland (14), Greece (28), and Belgium (20). Most studies had a small 
sample size (n < 100), with the exception of one population-based study (29) and five 
community-based or clinical populations (13,18,22,26,30). Two studies were conducted in 
adults 60 years and older (28,30). Most studies included more than 50% women (11–
14,16,18–20,22–27,29,31,32). All studies conducted in countries outside the United States 
and one conducted in the United States did not report on the distributions of race/ethnicity. 
Of the studies that did report on race/ethnicity, study samples were predominantly white 
(13,26).
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Study Design Characteristics—Current literature on the associations between 
depression and oxidative stress is primarily cross sectional. Few prospective studies have 
examined the effect of depression treatments on health outcomes, but only baseline data 
were used to calculate effect sizes. Age- and sex-matched healthy controls were included in 
most studies, with the exception of nine (20,23,24,27–32). Although unadjusted data were 
used to create comparable effect sizes estimates across studies for this meta-analysis, 
potentially confounding factors were dealt with through statistical adjustment in seven 
studies (13,17,26,29–31,33).
Depression Assessment Characteristics—Sixteen studies assessed depression using 
the DSM-IV criteria (11–26), two used the Hamilton Depression Rating Scale (27,32), one 
used the Center for Epidemiologic Studies Depression Scale (31), one used the Patient 
Health Questionaire-9 (29), one used the Beck Depression Inventory (30), one used the 
Geriatric Depression Scale (28), and one used a reliable but nonstandardized measure of 
depression called the Zung Self-Rating Depression Scale (33). Of the 16 studies assessing 
depression using the DSM-IV criteria, 7 additionally used the Hamilton Depression Rating 
Scale to assess severity of depressive symptoms (11,13,14,16,18,22,26).
Oxidative Stress Assessment Characteristics—The heterogeneity in oxidative 
stress and antioxidant status markers reported is shown in Table 1. A total of 12 measures of 
oxidative stress were described in these studies. The most frequently reported oxidative 
stress markers include malondialdehyde and nitric oxide (NO). Oxidative stress markers 
were most frequently collected from serum or plasma. The heterogeneity in measurement of 
antioxidant status markers was even greater. Investigators most commonly examined 
superoxide dismutase and glutathione peroxidase in analyses. Antioxidant status markers 
were most frequently collected from serum or plasma. Two studies collected their oxidative 
stress and antioxidant status markers from erythrocytes (14,21).
Study Results and Meta-Analyses
Meta-Analysis: Overall—Heterogeneity in oxidative stress and antioxidant status 
markers reported provided justification for calculating study-specific effect sizes based on 
the means and pooled standard deviations to determine an overall Cohen’s d effect size and 
the use of a random effects meta-analysis to pool effect size estimates. The pooled effect 
size estimates are presented separately for oxidative stress and antioxidant status markers 
collected. A Cohen’s d effect size estimate of 0.50 would suggest that depression was 
associated with a roughly ½ of a 1-standard-deviation increase in oxidative stress.
Figure 2 shows the forest plot of effect sizes when observing the associations between 
depression and oxidative stress measures. Among the 23 studies, 21 included a measure of 
oxidative stress and two reported on antioxidant measures only (22,25). The 21 studies 
yielded a pooled effect size (Cohen’s d) of 0.55 (95% confidence interval [CI] = 0.47–0.63). 
This value can be interpreted as a roughly 0.55 of 1-standard-deviation increase in oxidative 
stress among individuals with depression compared with those without depression. The test 
for heterogeneity yielded a significant I2 of 80.0% (p < .001).
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Figure 3 depicts the forest plot of effect sizes when observing the associations between 
depression and antioxidant status markers. Among the 23 studies, 16 had a measure of 
antioxidant status. The 16 studies yielded a statistically significant pooled effect size 
(Cohen’s d) of −0.24 (95% CI = −0.33 to −0.15). This value can be interpreted as a roughly 
0.24 of 1-standard deviation decrease in antioxidants among individuals with compared with 
those without depression. The test for heterogeneity yielded a significant I2 of 89.8% (p < .
001).
Quality Assessment of Reported Studies—Using guidelines from the STROBE 
statement, we created a checklist to assess the quality of included studies (Table 2). Among 
the 23 included studies, 5 met all the criteria for quality assessment (13,17,26,29,30). The 
methods/sources of participant selection were not clearly defined in two studies (11,31). 
With the exception of three studies, all others provided an adequate explanation of their 
assessment of depression (11,16,31). All studies provided a clear description of how 
depression and oxidative stress measures were handled in analyses. Although unadjusted 
analyses were used to create comparable effect sizes across studies in this meta-analysis, 
potentially confounding factors were dealt with through statistical adjustment in only seven 
studies (13,17,26,29–31,33).
A funnel plot of the study effect sizes and associated standard errors was created to check 
for possible publication bias (Fig. 4). Asymmetry is evident from visual inspection of the 
funnel plot. One limitation of our study is the inability to capture unpublished studies. Null 
association studies are at a higher risk for being unpublished, but for most of the studies 
included in this meta-analysis, the oxidative stress markers were secondary outcomes and 
would not have influenced a decision not to publish.
DISCUSSION
To our knowledge, this is the first systematic review and meta-analysis of the literature on 
the associations between depression and oxidative stress. In this pooled analysis of 23 
studies that met our inclusion criteria, depression was associated with increased oxidative 
stress and lower antioxidant status. This finding suggests a possible increase in oxidative 
stress marker levels or decrease in antioxidant status with greater depressive symptoms. 
Although the variability was greater in oxidative stress measures, the effect size relating 
high oxidative stress to depression was stronger than the effect size relating low antioxidant 
status to depression. These findings suggest a possibly greater impact of depression on 
oxidative stress than anti-oxidant status levels, necessitating interventions for targeting 
depression and subsequent elevations in oxidative stress.
Most studies included in this meta-analysis resulted in positive and significant effect 
estimates for the association between depression and oxidative stress (11–18,20–24,26–
28,30–33), whereas a few did not (19,25,29). The statistical test for heterogeneity was 
highly significant, suggesting that the treatment effect estimates are more variable between 
studies than would have been expected by chance alone. The studies varied widely in 
measures of both depression and of oxidative stress. Among the 23 studies, 7 different 
depression measures and 12 different oxidative stress markers were reported. Some of the 
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oxidative stress measures analyzed exhibited stronger associations with depression than 
others (e.g., malondialdehyde and 8-oxo-2′-deoxyguanosine). The selection of study 
participants was dissimilar between the studies, with several performed in clinical 
populations and a few conducted using healthy volunteers from the community. A clinical 
population may have included patients with mild, moderate, or severe depression. This is 
important to consider when comparing results across these studies because the degree of 
depressive symptoms may impact the level of an oxidative stress or antioxidant status 
markers present in the body.
Limitations
The results of this meta-analysis are subject to limitations. The heterogeneity among 
included studies should be considered when interpreting the results. The sample sizes ranged 
from 30 to 3000 consisting of individuals from 10 different countries. The strength of study-
specific effect sizes is highly dependent on the total sample size. Only 5 studies met all 
STROBE criteria at once, but 15 met all but one. In addition, the level of depression and 
coping mechanisms for depression may differ between individuals of differing cultural 
backgrounds. Seven different measurements of depression were used. Measurement of 
oxidative stress markers also varied widely with 12 different measures used. That an 
association between depression and oxidative stress was found even with a variety of 
methods and samples is also a strength because it is a more robust finding and not likely 
caused by consistent measurement artifact.
Strengths
Strengths of the study include that it was across many populations, sick and well, and of 
differing cultural backgrounds. A further strength is the use of the Cohen’s d statistical 
measure of effect size that allows us to pool the data from all available studies resulting in 
increased power for statistical analyses. Although there is significant heterogeneity between 
the studies, the use of Cohen’s d and random effects meta-analysis accounts for 
heterogeneity and ensures more valid estimates.
Future Research
As noted in the results, most of the literature on depression and oxidative stress is cross 
sectional. The literature would be strengthened by prospective research to assess whether 
depression is predictive of oxidative stress. It is possible that there are bidirectional causal 
associations between depressive symptoms and oxidative stress (9,35). Also, feedback 
mechanisms between psychological stress, such as depression, and oxidative stress might 
together contribute to adverse health and cognitive outcomes and accelerated aging (7,8). 
Prospective research is needed to tease this out.
Much of the literature was with whites and other ethnic majorities. As in the United States 
and other countries, where there is higher psychological stress including depression, in 
ethnic minorities, it would be useful to have more literature on these associations in ethnic 
minorities.
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In this pooled analysis of 23 studies, depression was associated with increased oxidative 
stress and lower antioxidant status. Findings from this analysis suggest that oxidative stress 
may be a mediating factor in the associations between depression and poor health outcomes. 
Further research needs to be conducted in this area, including prospective studies with larger 
sample sizes, consistency in standardized measures of depression, and biologically stable 
measures of oxidative stress.
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Flow diagram of study selection process.
Palta et al. Page 11























Cohen’s d (95% CI) for depression and oxidative stress. CI = confidence interval.
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Cohen’s d (95% CI) for depression and antioxidants. CI = confidence interval.
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Funnel plot for publication bias.
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